It has been found in glioma that increased Ras protein activity activates the downstream Raf/MEK/ERK signaling pathway, leading to upregulation of oncogene Bcl-2 expression and ultimately immortalizing tumor cells [60]. This evidence concerns the gene BCL2 and neoplasm.